WilmerHale Seminar: Examining New FDA Reporting Requirements
We will review the requirements of the new law, the government's efforts to implement it, and also share company perspectives, including compliance approaches and challenges and potential uses for competitor intelligence gathering. The new law affects all companies sponsoring or conducting clinical research, from large pharmaceutical companies to small biotechs.